Galectin Therapeutics
GALT
#8462
Rank
ยฃ0.20 B
Marketcap
ยฃ2.06
Share price
-4.27%
Change (1 day)
-49.67%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): -ยฃ0.35

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.36. In 2025 the company made an earnings per share (EPS) of -ยฃ0.37 an increase over its 2024 EPS that were of -ยฃ0.58.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.35-4.57%
2025-ยฃ0.37-36.84%
2024-ยฃ0.582.7%
2023-ยฃ0.5713.85%
2022-ยฃ0.5025%
2021-ยฃ0.4026.83%
2020-ยฃ0.315.13%
2019-ยฃ0.302.63%
2018-ยฃ0.29-22.45%
2017-ยฃ0.37-35.53%
2016-ยฃ0.58-13.64%
2015-ยฃ0.6712.82%
2014-ยฃ0.60-40%
2013-ยฃ0.9980.56%
2012-ยฃ0.55-32.08%
2011-ยฃ0.8113.98%
2010-ยฃ0.71-22.5%
2009-ยฃ0.92185.71%
2008-ยฃ0.32-70.83%
2007-ยฃ1.10118.18%
2006-ยฃ0.50-54.17%
2005-ยฃ1.10-14.29%
2004-ยฃ1.2847.37%
2003-ยฃ0.87-13.64%
2002-ยฃ1.01-24.14%
2001-ยฃ1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
-ยฃ9.34 2,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-ยฃ0.09937-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA